Expert Pitch

Rutgers Expert Available to Speak on Western Wildfires and Lung Health and Covid-19 Complications

Reynold Panettieri, a pulmonologist and vice chancellor for translational medicine and science director at Rutgers Institute for Translational Medicine, is available to comment on how smoke from the Western wildfires can affect the lungs and the steps people can take to stay safe.

“When inhaled, particulates, ozone and other combustible materials in smoke can cause lung damage. In most people without chronic conditions, high concentrations will result in an irritation of the upper airways, resulting in tearing eyes, coughing and mucus, which will go away when the irritant is avoided,” he says. “The smoke can exacerbate underlying conditions like asthma, COPD or pulmonary fibrosis. Most people who currently have or have recovered from Covid-19 will react similarly to a person without an underlying lung condition. However, those who were hospitalized with sustained symptoms or incurred significant lung injury are more at risk for increased damage from smoke exposure.”

Panettieri recommends that people in areas of exposure should stay indoors, keep windows closed and use air filters or run their air conditioners, which offer some air-filtering qualities. “If you must go outside, keep your car windows closed and wash your clothes when you get home as they can transmit the odors and toxins,” he says.




Filters close

Showing results

110 of 3755
Newswise: New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
Released: 22-Oct-2020 2:40 PM EDT
New Landmark Study at UM School of Medicine Finds Aspirin Use Reduces Risk of Death in Hospitalized COVID-19 Patients
University of Maryland Medical Center

Hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin, according to a new study led by researchers at the University of Maryland School of Medicine (UMSOM).

Released: 22-Oct-2020 2:25 PM EDT
Tocilizumab doesn't ease symptoms or prevent death in moderately ill COVID-19 inpatients
Massachusetts General Hospital

The drug tocilizumab (Actemra) does not reduce the need for breathing assistance with mechanical ventilation or prevent death in moderately ill hospitalized patients with COVID-19, according to a new study led by researchers at Massachusetts General Hospital (MGH).

Released: 22-Oct-2020 2:10 PM EDT
New York Gov. Andrew Cuomo said that nursing homes "never needed" to accept patients who tested positive for COVID-19, but they did accept them
Newswise

According to a report from the New York State Department of Health, "6,326 COVID-positive residents were admitted to [nursing home] facilities" following Cuomo's mandate that nursing homes accept the readmission of COVID-positive patients from hospitals. Therefore we rate his claim as false.

Released: 22-Oct-2020 2:10 PM EDT
U of M trial shows hydroxychloroquine does not prevent COVID-19 in health care workers
University of Minnesota

University of Minnesota Medical School physician researchers studied hydroxychloroquine as a treatment to prevent COVID-19 for those with high-risk for exposure to the virus - health care workers.

Newswise: UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
Released: 22-Oct-2020 1:50 PM EDT
UNLV Physician: Why COVID-19 Makes Flu Shots More Important Than Ever
University of Nevada, Las Vegas (UNLV)

As the race for a COVID-19 vaccine intensifies, health care officials are reminding the public not to forget another important vaccine this fall: the flu shot. Flu season in the U.S. technically began in September, with illnesses expected to peak in December and February, according to the Centers for Disease Control (CDC). Less than half of Americans received a flu vaccine during the 2019-2020 flu season, and a staggering 405,000 hospitalizations and 22,000 deaths were attributed to influenza.

Newswise: 246630_web.jpg
Released: 22-Oct-2020 1:45 PM EDT
Immune response the probable underlying cause of neural damage in COVID-19
University of Gothenburg

It is probably the immune response to, rather than the virus in itself, that causes sudden confusion and other symptoms from the nervous system in some patients with COVID-19. This is shown by a study of cases involving six Swedish patients, now published in the journal Neurology.

Released: 22-Oct-2020 1:35 PM EDT
COVID-19 study: Meaning in life and self-control protect against stress
University of Innsbruck

Numerous studies over the last few weeks have pointed out that the effects of the Corona pandemic on people's mental health can be enormous and affect large parts of the population.

Newswise: Hackensack Meridian CDI, University of Michigan Demonstrate Better, Faster COVID-19 Antibody Testing
Released: 22-Oct-2020 1:30 PM EDT
Hackensack Meridian CDI, University of Michigan Demonstrate Better, Faster COVID-19 Antibody Testing
Hackensack Meridian Health

A new portable “lab on a chip,” developed by the U-M scientists and demonstrated with help of the CDI, can identify the presence of COVID-19 antibodies in blood donors with greater speed and efficiency

Released: 22-Oct-2020 1:10 PM EDT
Relieving the cost of COVID-19 by Parrondo's paradox
Singapore University of Technology and Design

The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly across the globe at an alarming pace, causing considerable anxiety and fear among the general public.

Newswise: COVID-19 infection may be part of a ‘perfect storm’ for Parkinson’s disease
Released: 22-Oct-2020 1:00 PM EDT
COVID-19 infection may be part of a ‘perfect storm’ for Parkinson’s disease
Van Andel Institute

GRAND RAPIDS, Mich. (Oct. 22, 2020) — Can COVID-19 infection increase the risk of developing Parkinson’s disease?


Showing results

110 of 3755

close
0.91066